Sažetak Silymarin (Sil) was conjugated to selenium nanoparticles (SeNPs) to increase Sil
bioavailability. The conjugates were monodisperse; the average diameter of the native …

The past few years have seen substantial progress in veterinary oncology: new methods
have been developed for the diagnosis and treatment of oncological diseases in animals …

Background and objective: Previous studies have demonstrated the anti-cancer effects of
silymarin (SLM). However, the low bioavailability of SLM has restricted its use. This study …

Poor drug penetration, emerging drug resistance, and systemic toxicity are among the major
obstacles challenging the current treatment of cutaneous leishmaniasis. Hence, developing …

Background: The liver disease problem prompts investigators to search for new methods of
liver treatment. Introduction: Silymarin (Sil) protects the liver by reducing the concentration of …

A simple and solution-phase method for functionalization of selenium nanoparticles (SeNPs)
with Spirulina polysaccharides (SPS) has been developed in the present study. The cellular …

Background The purpose of this study was to develop a novel silymarin-loaded solid
nanoparticle system with enhanced oral bioavailability and an ability to provide excellent …

Objective The chemo-preventative and therapeutic properties of selenium nanoparticles
(SeNPs) have been documented over recent decades and suggest the potential uses of …

Selenium nanoparticles (SeNPs) are a unique type of nano-sized elemental selenium that
have recently found wide application in biomedicine. It has been shown that the properties …

Green synthesized nanoparticles possess potential bioactivity with low toxicity and
enhanced bioavailability and could be used for various biomedical applications …